Back to Investors
LV

Latitude Ventures

Venture Capital

Latitude Ventures is a series B plus sister fund to seed investor LocalGlobe, backing ambitious founders and emerging break-out companies.

Portfolio

5

companies


Portfolio companies

Dexory

Dexory

Dexory builds warehouse intelligence platforms powered by autonomous robots and artificial intelligence.

Automata

Automata

Automata builds modular laboratory automation platforms for the life sciences sector.

accuRx

accuRx

accuRx develops collaborative communication software that connects patients and healthcare teams.

Bloom & Wild

Bloom & Wild

Bloom & Wild provides online flower and plant delivery services across Europe.

Wagestream

Wagestream

Financial benefits provider delivering services for low and middle-income workers.


Team

Julian Rowe

Julian Rowe

partner

Julian brings investment and banking experience as a general partner at LocalGlobe, Latitude Ventures, Solar, and Phoenix Court, following an advisory role at J.P. Morgan.

LinkedIn

Recent investments

Series C
£124M

Eurazeo led the Series C financing, which will accelerate product development and international expansion.

"This new round allows us to bring forward transformational capabilities that our customers are asking for. By combining full-stack engineering with zero customer complexity, we are building advanced agentic systems powered by the industry’s richest set of real-world logistics data. This will help warehouses and supply chains shift from systems of record to true systems of action."
— Andrei Danescu, CEO and Co-Founder
Series B
£36.7M

The investment round was led by Octopus Ventures with participation from multiple returning and strategic backers.

"Automata’s robotic capabilities are truly the first of its kind and the company has combined this with deep expertise in automation and a highly effective business model which has created a leading-edge over competitors. Automata Labs accelerates human ingenuity, empowering labs, and scientists, to achieve consistent results faster, on a greater scale, and to ultimately upscale their ambitions. We are delighted to have led this financing round as Automata represented exactly the type of highly innovative company we invest in and support. We are excited for Automata’s next steps, both within the life sciences industry, and beyond."
— Jess McCreadie, Principal, Healthtech
Series B
£27.5M

The Series B round was led by Lakestar with backing from institutional investors and venture funds to support team growth and product expansion.

"accuRx’s product has reinvigorated communication with our patients, enabling a better relationship between GPs and patients, which has ultimately led to better care provision. Our patients now have the confidence that they’re getting speedy and accurate responses from our team, and the use of regular Florey questionnaires to gather more information from our patients has been transformative for clinical record keeping and the care we provide. We’re thrilled that accuRx has received funding which will enable it to expand its primary care product set, some of which we’re trialling at the moment. We’re also excited about accuRx’s progress into secondary care as better interaction between primary and secondary care is a huge step forward for safer and more effective patient care."
— David Triska, GP Partner
Series D+
£75.0M

General Catalyst led the round, which will finance the company's international growth strategy and technology scaling.

"We’ve been extremely fortunate in 2020 to accelerate our growth, strengthening our expertise in technology-enabled, customer-centric flower gifting. We’re privileged to have played our part in keeping people connected in this difficult period, and I’m proud of our growing team for scaling our operations whilst maintaining the signature thought and care we put into every order. With this new backing from General Catalyst and Index we start 2021 with renewed energy to pursue our vision of becoming the world’s leading and most loved flower company."
— Aron Gelbard, CEO and co-founder
Series B
£20.0M

Northzone led the £20m Series B round to support international expansion and strengthen UK market share.

"Where people work and how they work is changing by the day, all the more so since Covid-19 struck. Now the way in which people get paid is changing, too, and at scale. Wagestream provides a financial flexibility that is perfectly suited to today’s agile and progressive workforce."
— Peter Briffett, Co-founder and CEO